News | ACC | July 15, 2022

ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer

The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer

Melvin R. Echols, MD, FACC 


July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer, effective July 18. Echols will lead the College’s diversity, equity and inclusion strategy and programs, while also maintaining a portion of his current clinical and research responsibilities at Morehouse School of Medicine in Atlanta. 

"Fostering a diverse and inclusive cardiovascular workforce, while also advancing solutions to improve health equity among individual patients and populations, is fundamental to achieving ACC’s Mission of transforming cardiovascular care and improving heart health for all,” said ACC CEO Cathleen C. Gates. “As both a cardiologist and a cardiovascular disparities researcher, Dr. Echols brings a deep understanding of the profession, as well as demonstrated success in effectively advancing diversity, equity and inclusion initiatives and driving cultural change – competencies that will undoubtedly ensure we are able to deliver on our strategic diversity, equity and inclusion goals now and into the future.” 

Echols is currently an associate professor of cardiovascular disease at Morehouse School of Medicine and serves as program director for the Cardiovascular Disease Fellowship. He is also a practicing cardiologist specializing in heart failure and brings more than a decade of experience as a clinical trial investigator focusing on heart failure, quality improvement, social determinants of health, and health care disparities. In his role as Chief Diversity, Equity and Inclusion Officer, Echols will use his expertise and experiences to work with ACC members, staff, external partners and other stakeholders to identify and implement programmatic goals and develop actionable and sustainable solutions to achieving a more diverse, equitable and inclusive College and cardiovascular profession. Specifically, he will lead and facilitate ACC efforts to mitigate barriers to entry into the field of cardiology; build and expand educational initiatives like the new Internal Medicine Program; and lead and coordinate the diversity and inclusion efforts and training of both staff and members across the College. 

“In a time where polarization continues to permeate our society, we need the implicit core values of diversity, equity, and inclusion now more than ever,” Echols said. “I expect this role will permit me to listen actively, learn vigorously, and allow the needs of our society to lead the ACC towards impactful change.” 

Echols graduated from Morehouse School of Medicine in 2002 and completed Internal Medicine at Duke University in 2005. He completed his cardiovascular fellowship training at Duke University Medical Center. He is a member of the ACC, Association of Black Cardiologists, the Heart Failure Society of America, the American Society of Preventive Cardiology, and the American Heart Association

“The discovery of commonalities between people and culture while providing quality cardiovascular care to all is strengthened by diversity, and will ultimately improve health equity in our society,” Echols said. “Everyone has a part to play in this mission and should feel included in helping to make our society and the world better than yesterday.” 

For more information: www.acc.org 

Find more ACC22 conference coverage 


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now